Reduction in the incidence and mortality of colorectal cancer in Germany;Rückgang der Inzidenz und Mortalität von Darmkrebs in Deutschland

Deutsches Arzteblatt International

Volumn 113, Issue 7, 2016, Pages 101-106

  Brenner, Hermann ^a   Schrotz King, Petra ^a   Holleczek, Bernd ^b   Katalinic, Alexander ^c   Hoffmeister, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Epidemiologisches Krebsregister Saarland   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; COLORECTAL CANCER; GERMANY; AGE DISTRIBUTION; AGED; COLONIC NEOPLASMS; COLONOSCOPY; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; RISK FACTOR; SEX RATIO; SURVIVAL RATE; TRENDS; UTILIZATION; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLONOSCOPY; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 84959250112     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2016.0101     Document Type: Article

References (25)

1. Ferlay J, Soerjomataram I, Ervik M, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr (last accessed on 17 August 2015).
2. Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland (eds.): Krebs in Deutschland 2009/2010. Berlin: Robert Koch-Institut 2013.
3. Brenner H, Altenhofen L, Stock C, Hoffmeister M: Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol 2015; 13: 717-23.
4. Brenner H, Altenhofen L, Stock C, Hoffmeister M: Natural history of colorectal adenomas: Birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev 2013; 22: 1043-51.
5. Brenner H, Altenhofen L, Stock C, Hoffmeister M: Expected long-term impact of the German screening colonoscopy program on colorectal cancer prevention: analyses based on 4, 407, 971 screening colonoscopies. Eur J Cancer 2015; 51: 1346-53.
6. Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (GEKID): GEKID Atlas. www.gekid.de/Atlas/Tabellen/Tabellen-D.php (last accessed on 22 November 2015).
7. Epidemiologisches Krebsregister Saarland: Interaktive Datenbank. www.krebsregister.saarland.de/datenbank/datenbank.html (last accessed on 22 November 2015).
8. Atkin WS, Edwards R, Kralj-Hans I, et al.: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-33.
9. Segnan N, Armaroli P, Bonelli L, et al.: Once-only sigmoidoscopy in colorectal cancer screening: Follow-up findings of the Italian Randomized Controlled Trial - SCORE. J Natl Cancer Inst 2011; 103: 1310-22.
10. Brenner H, Stock C, Hoffmeister M: Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467.
11. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M: Reduced risk of colorectal cancer up to 10 years after screening surveillance or diagnostic colonoscopy. Gastroenterology 2014; 146: 709-17.
12. Stock C, Ihle P, Sieg A, Schubert I, Hoffmeister M, Brenner H: Adverse events requiring hospitalization within 30 days after outpatient screen - ing and non-screening colonoscopy. Gastrointest Endosc 2013; 77: 419-29.
13. Kraywinkel K, Bertz J, Laudi A, Wolf U: Epidemiologie und Früh - erkennung häufiger Krebserkrankungen in Deutschland. Berlin: Robert Koch-Institut (ed.) 2012; GBEkompakt 3(4). www.rki.de/gbe-kompakt (last accessed on 13 January 2016).
14. Hoffmeister M, Chang-Claude J, Brenner H: Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol 2007; 166: 130-6.
15. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P: Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 2765-78.
16. John U, Hanke M: Lung cancer mortality and years of potential life lost among males and females over six decades in a country with high smoking prevalence: an observational study. BMC Cancer 2015; 15: 876.
17. Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilization of hormone replacement therapy. Breast Cancer Res Treat 2008; 107: 427-30.
18. Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A: Colorectal cancer incidence in Germany: stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol 2012; 36: 417-20.
19. Ahmed S, Johnson K, Ahmed O, Iqbal N: Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 2014; 29: 1031-42.
20. Brenner H, Kloor M, Pox C: Colorectal cancer. Lancet 2014; 383: 1490-502.
21. Segnan N, Patnick J, von Karsa L (eds.): European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st edition. Lyon: International Agency for Research on Cancer 2010.
22. Riemann JF, Maar C, Betzler M, Brenner H, Sauerbruch T: Darmkrebsfrüherkennung im Nationalen Krebsplan - derzeitiger Stand und Empfehlungen. Z Gastroenterol 2011; 49: 1428-31.
23. Stock C, Pulte D, Haug U, Brenner H: Subsite-specific colorectal cancer risk in the colorectal endoscopy era. Gastrointest Endosc 2012; 75: 621-30.
24. Siegel RL, Ward EM, Jemal A: Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012; 21: 411-6.
25. Siegel R, Desantis C, Jemal A: Colorectal cancer statistics 2014. CA Cancer J Clin 2014; 64: 104-7.